What are the economics of war?

What are the economics of war?


More countries are boosting their defense industries, calling for a shift to “war economy mode.” But what exactly is a war economy?

Last March, Thierry Breton, the EU’s commissioner for internal market, advocated for a shift of the European defense industry toward a war economy.

Europe is facing an “existential threat,” he said, as the Commission announced a new defense strategic plan, with a minimum of €1.5 billion ($1.6 billion) subsidy to boost the continent’s war machine.

Nations are investing in their armed forces too.

In Germany, arms maker Rheinmetall inaugurated a new factory in February that will produce artillery ammunition, explosives and rockets.

Aerospace and defense company Kongsberg also opened a new anti-ship and cruise missile manufacturing plant in Norway last June.

According to the Stockholm International Peace Research Institute, military expenditure reached a peak of $2.4 trillion in 2023, the highest year-on-year rise since 2009.

Watch the video above to learn more about the economics of war. 



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More